Urinary amino acid excretion in acute leukemia.
Urinary amino acid excretion was determined in 31 leukemic patients and 29 normal individuals by rapid gas chromatographic analysis of 16 amino acids as their N-acetyl-n-propyl esters. The leukemic patients were concurrently undergoing, or had recently completed, chemotherapy. It was found that aspartic acid, threonine, and serine were of significance in distinguishing between patients "on" therapy and those "off" therapy. Patients with advanced disease have the greatest aminoaciduria, although both the normal and leukemic populations have wide individual ranges. Within both populations, men excrete a greater variety and quantity of amino acids than women. It is concluded that analysis of urinary amino acids represents a history of complex metabolic events, which is potentially useful for evaluating patient response to chemotherapy in leukemia.
D000596:Amino Acids / Q000652:urine*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001224:Aspartic Acid / Q000652:urine; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism / Q000652:urine*; D008297:Male; D012075:Remission, Spontaneous; D000608:Renal Aminoacidurias / Q000209:etiology; D012694:Serine / Q000652:urine; D013912:Threonine / Q000652:urine
D000596:Amino Acids; D000970:Antineoplastic Agents; D013912:Threonine; D001224:Aspartic Acid; D012694:Serine